Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Recipharm AB (publ)
  6. Summary
    RECI B   SE0005757267

RECIPHARM AB (PUBL)

(RECI B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Financials
Sales 2019 7 461 M 896 M 896 M
Net income 2019 343 M 41,2 M 41,2 M
Net Debt 2019 4 152 M 499 M 499 M
P/E ratio 2019 29,4x
Yield 2019 -
Sales 2020 11 124 M 1 336 M 1 336 M
Net income 2020 339 M 40,7 M 40,7 M
Net Debt 2020 8 932 M 1 073 M 1 073 M
P/E ratio 2020 55,3x
Yield 2020 -
Capitalization 23 481 M 2 766 M 2 821 M
EV / Sales 2019 1,90x
EV / Sales 2020 2,79x
Nbr of Employees -
Free-Float 56,3%
More Financials
Company
Recipharm publ AB is a Sweden-based pharmaceutical company, operating as a Contract Development and Manufacturing Organization (CDMO). It is divided in two business areas: Manufacturing Services, supplying a range of pharmaceutical products in different dosage forms, such as solid dose, semi solids, beta-lactams, hormones, dry powder metered dose inhalers, oral liquids and granulates, among others; and Development... 
Sector
Pharmaceuticals
Calendar
07/23 | 01:45amEarnings Release
More about the company
Ratings of Recipharm AB (publ)
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
B-
More Ratings
All news about RECIPHARM AB (PUBL)
04/13NANOLOGICA  : Nomination Committee Proposes Thomas Eldered as New Board Member o..
AQ
04/09RECIPHARM  : Notice to attend the annual general meeting of Recipharm AB (publ)
AQ
03/02RECIPHARM  : names 2020 International Environmental Award winner
AQ
03/01EQT  : Roar BidCo announces final outcome in the offer to the shareholders in Re..
AQ
02/22RECIPHARM  : Delisting of shares from Nasdaq Stockholm
AQ
02/19RECIPHARM  : Nasdaq Stockholm Approves Recipharm's Delisting Request
MT
02/19RECIPHARM  : Delisting of shares from Nasdaq Stockholm
AQ
02/17RECIPHARM AB  : - Notice of extraordinary general meeting in Recipharm AB :
AQ
02/16RECIPHARM  : Notice of extraordinary general meeting in Recipharm AB (publ)
AQ
02/15RECIPHARM  : applies for delisting of shares and summons to extraordinary genera..
AQ
02/15EQT  : Closes Offer Period for Recipharm Acquisition With Over 95% Stake
MT
02/15EQT  : Roar BidCo declares the offer to the shareholders in Recipharm AB (publ) ..
AQ
02/11EQT  : Recipharm Takeover Receives European Commission Approval
MT
02/10EQT  : Roar BidCo has received competition clearance from the EU Commission for ..
AQ
02/10RECIPHARM  : bolsters biologics offering
AQ
More news
News in other languages on RECIPHARM AB (PUBL)
02/08Eurazeo prépare une vente du groupe pharmaceutique Seqens, selon des sources
01/28EN DIRECT DES MARCHES  : STMicroelectronics, Elior, TechnipFMC, Valneva, Apple, ..
01/11La bourse reste hermétique au déclin de Trump
01/11AVIS D'ANALYSTES DU JOUR  : Air Liquide, Airbus, Aperam, Fresenius, LafargeHolci..
2020Pas de Brexit, pas de plan US, mais des vaccins
More news
Chart RECIPHARM AB (PUBL)
Duration : Period :
Recipharm AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Thomas Bengt Eldered Chief Executive Officer & Director
Tobias Hägglöv Chief Financial Officer
Richard Ridinger Chairman
Per Anders Gustav Carlberg Independent Director
Marianne Dicander Alexandersson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RECIPHARM AB (PUBL)6.02%2 766
MERCK KGAA10.55%81 596
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD51.17%38 130
KYOWA KIRIN CO., LTD.33.80%18 130
SK BIOPHARMACEUTICALS CO., LTD.-29.59%8 516
BETTA PHARMACEUTICALS CO., LTD.-0.39%6 906